Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2022

Jan 10, 2023

BUY
$4.09 - $6.86 $44 - $75
11 Added 110.0%
21 $0
Q3 2022

Oct 19, 2022

SELL
$5.41 - $6.74 $324 - $404
-60 Reduced 85.71%
10 $0
Q2 2022

Jul 12, 2022

BUY
$2.18 - $6.39 $152 - $447
70 New
70 $0

Others Institutions Holding FSTX

About F-star Therapeutics, Inc.


  • Ticker FSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,584,700
  • Description
  • F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck c...
More about FSTX
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.